Bond AbbVie 4.875% ( US00287YEN58 ) in USD
| Issuer | AbbVie | ||||||||||
| Market price | |||||||||||
| Country | United States
|
||||||||||
| ISIN code |
US00287YEN58 ( in USD )
|
||||||||||
| Interest rate | 4.875% per year ( payment 2 times a year) | ||||||||||
| Maturity | 09/14/2031 | ||||||||||
| Minimal amount | 2 000 USD | ||||||||||
| Total amount | 1 500 000 000 USD | ||||||||||
| Cusip | 00287YEN5 | ||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||||||
| Next Coupon | 03/14/2027 ( In 126 days ) | ||||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEN58, pays a coupon of 4.875% per year. The coupons are paid 2 times per year and the Bond maturity is 09/14/2031 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEN58, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEN58, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||
| |||||||||||
Français
Italiano
United States